October 10, 2024 Professional Services Program – Reimbursement Methodology LAC 50:IX.15113

-

Back to Main Notices of Intent Page

Back to Rulemaking Home Page

 

Amends the provisions governing reimbursement methodology in the Professional Services Program in order to allow coverage of physician-administered biosimilar drugs in Mary Bird Perkins Cancer Centers and establish the reimbursement methodology for their use.

 

Contact Information:  Kimberly Sullivan, JD, Bureau of Health Services Financing, P.O. Box 91030, Baton Rouge, LA 70821-9030


Disclaimer:  Please note that the official versions of the Notices of Intent are maintained by the Office of State Register’s website at http://www.doa.louisiana.gov/osr/osr.htm.  The excerpted versions of these Notices of Intent contained on this website are provided as a courtesy service to the public and is unofficial and should not be regarded as such. Users are encouraged to visit the Office of State Register’s website for the official version.

RELATED ITEMS

Emergency Rule: N/A

Notice of Intent

Prior to Proposed Rule:  August 2024 LAC

Proposed Rule

October 20, 2024 (Louisiana Register)

Surgeon General Ralph L. Abraham, M.D.

Secretary Bruce D. Greenstein

Powered by Cicero Government